Health Condition 1: D249- Benign neoplasm of unspecified breast Health Condition 2: N644- Mastodynia
Conditions
Interventions
Intervention1: Centchroman: Centchroman 30mg twice weekly for 3 months
Control Intervention1: NIL: NIL
Sponsors
Dr Kajal Chauhan
Eligibility
Inclusion criteria
Inclusion criteria: 1. All patients giving consent to be the part of study 2. Females of age less than 35 who had mastalgia with or without nodularity 3. Patients with fibroadenoma of size 1.5 to 3cms 4. Patients not willing for excision 5. Patients presenting with complaints of breast lump in less than 35years of age
Exclusion criteria
Exclusion criteria: 1. Patients not willing to participate in study 2. Patients more than 35years of age 3. Patients who are pregnant, lactating and planning for pregnancy in near future 4. Patients with PCOD 5. Patients who have history of breast carcinoma or family history of breast carcinoma 6. Patients with complex fibroadenoma
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in mastalgia severity using visual analog scoreTimepoint: Baseline (day 0), 4 weeks, 8 weeks and 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Change in size of fibroadenoma on USG 2. Incidence of adverse effects related to centchroman during the study periodTimepoint: Day 0, 8 weeks and 12 weeks | — |
Countries
India
Contacts
Public ContactDr Prof Rajeev Kumar Singh
Government Medical College Haldwani
Outcome results
None listed